Editor's key points † This study in rats demonstrates that the pharmacodynamics of non-depolarizing neuromuscular blocking agents in sepsis is associated with the expression of a7-and g-nAChR in the skeletal muscle. † Ulinastatin, a protease inhibitor, can improve the effects of systemic inflammation on the expression of these receptors.
junction. 21 Acetylcholine-induced electrical activity suppresses the expression of a7-and g-nAChR. Thus, we hypothesized that the expression of a7-and g-nAChR can be improved by ulinastatin treatment. This study in rats tested the hypothesis that the expression of a7-and g-nAchR on the septic muscle attenuates the muscle-relaxing effect of NMBAs. We used surgical peritonitis to induce a sepsis model avoiding steroid use or surgical denervation to investigate the alteration of neuromuscular block properties of vecuronium, a non-depolarizing NMBA. We also assessed neuromuscular function in relation to mRNA encoding for the g-and a7 subunits of acetylcholine receptor and for the expression of protein receptors.
Methods

Animals
Male Sprague -Dawley rats (age: 2-3 months, weight range: 200 -220 g) were obtained from the Experimental Animal Centre of Chongqing Medical University (Chongqing, China). All rats received humane care according to the Care and Use Committee of Chongqing Medical University. One week before the experiments, the rats were housed in a specific pathogen-free laboratory in an acclimatized room at standard room conditions [25 (2) 8C, 55% humidity] with a 12 h light/dark cycle. The rats were given free access to water and standard chow. All experimental procedures involving animals were approved by the Animal Ethics and Use Committee of Chongqing Medical University.
Anaesthesia and vital parameters
For neuromuscular functional and pharmacological studies, the animals were anaesthetized with 10% chloral hydrate [350 mg kg 21 intraperitoneal (i.p.)] on the day of the experiment. The animals were tracheotomized, and their lungs were mechanically ventilated. The mean arterial pressure, heart rate and body temperature (8C) were continuously monitored. Pa O 2 , Pa CO 2 , and acid -base status were intermittently measured and corrected to ensure stable haemodynamic conditions. The rats were excluded from the experiment if haemodynamically unstable (mean arterial pressure ,10. 
Animal models and group assignments
For surgical intervention, the rats were anaesthetized with i.p. administration of 10% chloral hydrate (350 mg kg 21 ). All the rats were weighed daily and randomly divided into two groups: (i) the sepsis group in which caecal ligation and puncture (CLP) was performed; and (ii) the sham group in which a sham operation was performed (n¼6). Given the time frame of the sepsis model, the rats in the sepsis group were assigned to four subgroups: Day 1 (n¼6), Day 3 (n¼6), Day 7 (n¼12), and Day 14 (n¼24). After 10 days of CLP, the rats in the sepsis group were i.v. injected with ulinastatin (5000 U kg 21 ) (n¼12) or 0.9% normal saline (NS) (n¼12). The group assignments are shown in Figure 1 .
In the sepsis group, sepsis was induced by CLP, which was performed as described previously. 22 In this sepsis model, the rats were considered septic at 6 h after CLP. 23 Midline laparotomy was performed to expose the caecum. The caecum was ligated tightly with a 3-0 silk suture at its base below the ileocaecal valve and punctured with a 24-gauge needle avoiding bowel obstruction. A small amount of faeces was exteriorized by gentle pressure applied on the ligated caecum. Then, the caecum was returned to the peritoneal cavity. The abdomen was closed with 3-0 silk. The rats in the sham group received 
Evaluation of neuromuscular function
Electromyographic (EMG) recordings were measured at preand post-modelling. The data were obtained from the right sciatic nerve that was stimulated supramaximally (intensity, 3 V; duration, 0.2 ms; and frequency, 1 Hz) by a direct stimulation electrode (RM6240 Systems, Inc., Cheng Du, China) from the sciatic nerve. Compound muscle action potential (CMAP) was recorded using a superficial disc electrode located on the tibialis anterior muscle before and at different times after surgery, as described previously. 24 Electromyographical analysis used the RM6240USB2.0S (I) version 1.0.2 software (RM6240 Systems, Chengdu Instrument Company, Chengdu, China), with amplitude, and duration of CMAP as the parameters. The motor conduction velocity (MCV) was calculated as the distance of conduction/latency time. The temperature of each rat was kept at 36 -378C using a heating light. Neuromuscular dysfunction was defined as a decrease of ≥20% of the lower limit of the normal CMAP amplitude. 25 26 Pharmacodynamics of vecuronium Neuromuscular block was monitored by evoked mechanomyography using a nerve stimulator (RM6240 Systems) and a RM6240-JZJ100 force transducer (RM6240 Systems). The rats were placed in the dorsal recumbent position. The tendon of the tibialis anterior muscle on each side (left or right side by random selection) was surgically exposed, severed, and then individually attached to separate transducers. Both sciatic nerves were exposed at the thigh. Stimulation electrodes were attached to measure nerve-mediated contraction of the tibialis anterior muscle. To ensure a force vector control, we stabilized each knee rigidly with a clamp. A preload of 30 g was applied to yield maximal isometric contractions. The nerve-evoked tensions of the respective tibialis anterior muscles were recorded by an amplifier and displayed using the RM6240USB2.0S (I) version 1.0.2 software. The isometric twitch tension of the tibialis anterior muscle was estimated by researchers who were blinded from the experimental group of each specimen. Twitch tension was elicited by indirect supramaximal constant current stimulation at 0.1 Hz using a stimulator and a constant-current unit to deliver twitch tension. All forces were measured in grams. After the elicited twitch tension was stabilized, single-twitch tension (averaged in groups of five) was determined. The potency of vecuronium was tested using the cumulative dose -response method. Bolus doses of vecuronium were administered i.v. in increments of 0.05-1 mg kg 21 until the twitch height achieved maximal depression. Each incremental dose was given only after the twitches were allowed to recover to baseline values. The twitch tension inhibitory effect was normalized by the following equation: % inhibition¼100× (12A/B), where A represents the minimal twitch height in the presence of vecuronium and B is baseline values of twitch height. Dose-response analysis: inhibitory effect vs dose data was fitted using a four-variable logistic sigmoidal doseresponse model. The expression relating the dose to the inhibitory effect is as follows:
where Y represents the fraction of inhibition, START refers to Y for the minimal response, END is Y for the maximum response, n is the Hill coefficient (considered as a slope parameter), x is the administered dose, and 50% inhibitory concentration (IC 50 ) is the effective dose eliciting 50% of the maximal effect.
Tissue preparation
The animals were humanely killed by deep anaesthesia with sodium pentobarbital (65 mg kg 21 i.p.), the tibialis anterior muscle specimens of rats were collected in 4% paraformaldehyde or liquid nitrogen.
Immunohistochemistry
Immunostaining was performed using the streptavidinperoxidase method. For detection of a7-nAchR, the muscle specimens were immediately fixed with 4% paraformaldehyde in phosphate buffer saline (PBS) and embedded in paraffin.
Another muscle specimens were collected in liquid nitrogen and were fixed in cold acetone for 1 2 min. The endogenous peroxidase was inactivated by incubating the tissue sections in 3% hydrogen peroxide for 30 min at 258C. The sodium citrate buffer (0.01 mol litre 21 , pH 6.0) was used to retrieve antigen at 96-988C for 10 min. Then, the rabbit anti-nAChR a7 pAb (ab10096, Abcam Ltd, dilution 1:800) was added into a humidity chamber and was incubated with samples at 48C overnight. For detection of g-nAchR, the muscle specimens were collected in liquid nitrogen. Tissue sections were fixed in cold acetone for 1 2 min and rehydrated in PBS. The antinAChR g pAb (LS-C73537, LSBio, Inc., dilution 1:1000) was applied to the tissue sections. Then following anti-rabbit (for a7-nAchR) or -mouse (for g-nAchR) IgG secondary antibodies were used to detect each primary antibody. The sections were routinely counterstained with haematoxylin. Controls consisted of unstained and secondary antibody alone sections where all, or just the primary, antibodies were replaced with dilution buffer. The average optical density was analysed in 10 randomly selected microscopic fields in five sections of each group at a 400-fold magnification.
Western blot analysis
Tissues were homogenized using lysis buffer (Beyotime, China), and supernatants were collected after centrifugation at 12 000×g for 15 min at 48C. After quantitative analysis of protein concentration, total proteins were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis, transferred to polyvinylidene fluoride membranes (Millipore, Billerica, MA, USA), blocked with 5% non-fat milk in Trisbuffered saline for 1 h at 378C, and then incubated overnight at 48C with sc-13998 (Santa Cruz, Inc., dilution: 1:500) and ab10096 (1:1000) as primary antibodies. After incubation for 1 h at 378C with secondary antibody (1:2000; Beyotime), bands were seen using the enhanced chemilumine-scence kit (Beyotime) according to the manufacturer's protocol. All results were normalized to glyceraldehyde-3-phosphate dehydrogenase (GAPDH) levels.
Real-time polymerase chain reaction analysis
The mRNA encoding for g-and a7 subunits are CHRNG and CHRNA7, respectively. Total cellular RNA was isolated from the tibialis anterior muscle with TRIzol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. Real-time quantitative polymerase chain reaction (PCR) was performed using iQ SYBR Green Supermix on the iCycler iQ detection system (Bio-Rad, Hercules, CA, USA). The standard reaction volume was 20 ml and contained 1 ml QuantiTect SYBR Green PCR Master Mix (Qia-gen, Valencia, CA, USA), 0.1 U AmpErase uracil N-glycosylase (UNG) enzyme (PE Biosystems, Foster City, CA, USA), 0.7 ml cDNA template, and 0.25 mM forward and reverse primers. The initial step of PCR was 2 min at 508C for AmpErase UNG activation, followed by a 15 min hold at 958C. The reverse transcriptase (RT) -PCR programme on iCycler was 958C for 15 s, 608C for 30 s, and 728C for 30 s. All experiments were confirmed with three animals. The expression levels for each gene of interest were calculated by normalizing the quantified mRNA amount to the quantified mRNA amount of GAPDH. Primers for g and a7 genes were designed using the Primer Express software (Perkin-Elmer, Foster City, CA, USA). Primer sequences are given in Table 1 .
Statistical analysis
Competition analysis data [IC 50 and slope at IC 50 ] were determined from a four-variable logistic sigmoidal dose -response model fitted to the dose -response curves with Prism 4 (GraphPad Software, Inc., San Diego, CA, USA). Data on twitch tension inhibition rate were expressed as mean (SEM). IC 50 values were expressed as means with 95% confidence intervals, whereas the IC 50 ratio and slope at log IC 50 were expressed as mean (SD). The IC 50 ratio was defined as the IC 50 of the dose -response curve in the sepsis group divided by that in the sham group. The remaining data were expressed as mean (SD). Real-time PCR data analysis was performed using the Q-Gene software, which expresses data as mean normalized expression (MNE).
MNE is directly proportional to the RNA amount of the target gene relative to the RNA amount of the reference gene. Statistical significance was assessed using one-way repeatedmeasures analysis of variance (ANOVA) followed by ANOVA with the Scheffé F-test. A P-value of ,0.05 was considered to indicate statistical significance.
Results
Mortality, behaviour, and weight gain
No deaths occurred in the sham-operated rats (n¼30). All deaths associated with CLP occurred after 5 days after laparotomy. The mortality rates were 25% (3 in 12 rats) on Day 7, 41% (5 in 12 rats) on Day 14 for 0.9% NS, and 33% (4 in 12 rats) on Day 14 for ulinastatin after CLP. Almost all of the CLP animals demonstrated crouching, piloerection, decreased spontaneous locomotor activity, and exudation around the eyes from Day 1 to Day 3 after laparotomy. From Day 6 to Day 7, 14 rats progressed to septic shock and 12 rats to death. The rats with septic shock were immobilization and showed motor restlessness, hair erection, and subconjunctival haemorrhage. At necropsy of the dead animals, the peritoneal cavity contained a large amount of bloody and malodorous fluid, and the caecum was distended and gangrenous. Only three rats did not exhibit the symptoms described above. Surviving CLP rats developed diarrhoea and failed to gain weight. From Day 9, the animals gained weight in parallel to that of the sham rats. However, decreased spontaneous locomotor activity and ruffled fur visually distinguished the CLP rats from the sham rats throughout the observation period.
Electrophysiological recordings
The CMAP recorded for each group is shown in Figure 2A . In the sham group, the amplitude of CMAP was 16.51 (2.53) mV. However, in the sepsis group, the amplitudes of CMAP decreased significantly, and the peak appeared on Day 7 postoperation (P,0.01; Fig. 2B ). The duration of CMAP in the sepsis group was prolonged significantly, and the peak appeared on Day 7 post-operation (P,0.01). No significant difference was found between the duration of CMAP in the Day 14 group and that in the ulinastatin group (P.0.05; Fig. 2C ). The nerve conduction velocity significantly decreased in the sepsis group compared with that in the sham group (P,0.05). The peak appeared on Day 7. The nerve conduction velocity recovered slightly after ulinastatin administration (P,0.01; Fig. 2D ). In the sepsis group, the twitch tension magnitudes elicited by continuous stimulations were the largest in the Day 1 group, second largest in the Day 3 group, and smallest in the Day 14 group (P,0.05). No significant difference was found between Table 1 Primer sequences for g-and a7 subunits of nAChR
the twitch tension elicited by stimulation in the Day 7 group and that in the ulinastatin group (P.0.05; Fig. 2E ).
Vecuronium dose -response curves
Vecuronium reduced the magnitudes of indirectly elicited twitch tensions in a dose-dependent manner (P,0.01; Fig. 3 ). Fitting the vecuronium dose -response data to the fourvariable logistic equation yielded IC 50 values, which quantitatively indicate the position of the curve. The IC 50 of vecuronium gradually increased from Day 1 to Day 14 in the sepsis group (P,0.01; Table 2 ). However, the IC 50 of vecuronium in the rats with ulinastatin was significantly lower than that in the rats with 0.9% NS in the Day 14 group (P,0.01). It was close to the IC 50 of the Day 7 group (P.0.01). The IC 50 ratio, which standardizes the magnitudes of the rightward shifts of the dose -responses curves, was significantly the largest for the rats with 0.9% NS, second largest for the rats in the ulinastatin and Day 7 groups, and smallest on Days 1 and 3 in the sepsis group (P,0.01). The slope at IC 50 , which characterizes the slope of the curves, was not significantly different between the sham and Day 1 in the sepsis group (P.0.05).
In the sepsis group, the slope at IC 50 gradually increased from Day 1 to Day 3 in the sepsis group (P,0.01). The slope at IC 50 for the rats with 0.9% NS was significantly less than that of the rats with ulinastatin in the Day 14 group (P,0.01; Table 2 ).
Immunohistochemical staining
In the sham muscle specimens, g-and a7-nAChR stains were not observed in the skeletal muscle membrane. In the septic Pharmacodynamic changes with vecuronium muscle specimens, the skeletal muscle membrane showed gand a7-nAChR immunoreactivity from Day 1 to Day 14 ( Fig. 4A) . On Day 14, the number of g-and a7-nAChR on the skeletal muscle membrane peaked by positive immunostaining with anti-nAChR g antibody and anti-nAChR a7 antibody (Fig. 4B) . After ulinastatin administration, the expression levels of g-and a7-nAChR decreased in the skeletal muscle membrane on Day 14, compared with those on Day 7 (P,0.05).
Western blotting and RT-PCR
The relative protein levels to GAPDH of g-and a7-nAChR significantly increased on Days 1, 3, 7, and 14 in the sepsis group compared with those in the sham group. The peak value appeared on Day 7 and 14 post-procedure for g-and a7-nAChR, respectively, by semi-quantitative analysis (P,0.05; Fig. 5 ).
The g-and a7 subunits of mRNA were detected in all muscle samples by RT-PCR. Similar to the results of western blot, the ratio of g-and a7-mRNA to GAPDH mRNA significantly increased on Days 1, 3, 7, and 14 in the sepsis group compared with that in the sham group. The peak value appeared on Day 7 and 14 post-procedure for g-and a7-nAChR, respectively (P,0.05; Fig. 6 ).
Correlation between IC 50 of vecuronium and g-nAchR, or a7-nAchR protein Statistically significant positive correlations were found between the IC 50 of vecuronium and g-nAchR protein level in the sepsis group (r¼0.864, P¼0.026). The level of a7-nAchR protein was correlated positively with the IC 50 of vecuronium in the sepsis group (r¼0.765, P¼0.002).
Discussion
The results of this study demonstrated that sepsis results in resistance to the neuromuscular effect of vecuronium. This Pharmacodynamic changes with vecuronium resistance manifested itself as early as Day 3 after CLP operation, persisted until Day 7, and recovered to some extent after ulinastatin administration. This resistance is related to qualitative (isoform) changes in the receptor. These receptors have different electrophysiological properties and ligandspecific sensitivity or affinity. This study has documented a relation between expression of a7-and g-nAchR and resistance to NMBAs. We used a septic neuromyopathy model that is considered to be more appropriate to study the physiopathology of neuromuscular disorders. 27 28 CLP-induced sepsis is characterized by a hyperdynamic state in the early phase (the first 5 days after CLP) followed by a hypodynamic state in the chronic phase (6-28 days after CLP) in the laboratory. It is considered more relevant to clinical sepsis. 29 -31 It has been reported that acute sepsis stage-dependently attenuated the effect of NMBAs. 32 However, the effect of chronic sepsis on NMBAs is still unclear. In the endotoxin model of repeated i.p. injections of lipopolysaccharide into mice, Tomera and Martyn 33 reported a three-fold shift to the right of the dose -response curve of d-tubocurarine after 2 weeks. In this study, the rightward-shift magnitudes of the dose -response curves of vecuronium increased about threefold at 14 days after CLP. Nevertheless, the rightward shift can be reversed partially by ulinastatin administration. The results suggest that systemic inflammation is an important factor, resulting in resistance to NMBAs in sepsis.
The mechanisms of sepsis-induced resistance to NMBAs include increased binding of NMBAs to a1-acid glycoprotein (AAG) 11 and facilitated endplate potentials. 34 AAG is a secondphase acute phase protein, which was primary protein binding to NMBAs. Its serum concentration increases 48 h after tissue injury. And this change reaches a maximum after 3-4 days and slowly declines during the next 10-14 days. Fink and colleagues reported that resistance to atracurium during systemic inflammation is attributable to increased drug binding to AAG. They used an a-bungarotoxin to quantitate the nAChRs. Nevertheless, this ligand does not differentiate nAChRs in muscles. 4 35 Kim and colleagues 36 demonstrated the capacity of AAG binding to NMBAs, which was significant but limited. Martyn's group reported resistance to neuromuscular blockade induced by NMBAs in burned and trauma was related to up-regulation of nAChRs. Elevated plasma binding did not explain the potentiating effect of resistance to NMBAs. 7 16 37 In our study, g-and a7-nAChR were found on the skeletal muscle membrane by molecular biological and immunological techniques. The levels of these receptors were highly correlated with the IC 50 of the dose -response curves of vecuronium. These results suggested that sepsis-induced hyposensitivity to NMDAs was associated with changes in the quality of postjunctional nAChR. The reduced slope of dose -response curves in septic rats also indicated that sepsis altered the affinities of nAChR to NMDAs, which also originated from quality alteration of nAChR. Thus, different pharmacokinetic and pharmacodynamic factors can potentially contribute to this resistance. Compared with 1-nAChR, 1/10th -1/100th doses of agonists affect depolarization in the g-nAChR.
18 38 39 Low antagonist concentration effectively antagonizes the actions of iontophoeretically applied Ach in nAChR. 17 a7-AChR has a lower affinity for antagonists. Chiodini and colleagues 40 investigated the effects of atracurium on a7-nAChR by biochemical and electrophysiological methods. A comparable inhibition of acetylcholine-evoked current for a7-nAChR was rapid and readily reversible. Higher concentrations of these drugs were required to block a7-AChR than 1-nAChR. 41 Thus, g-and a7-nAChR expressed on the muscle membrane can lead to lower affinity for NMBAs, thus requiring higher concentration of these drugs for inhibition. The preliminary indirect evidence indicated that inflammatory cytokines and magnesium can produce a 'denervation-like state'. 42 The denervation-like state of the skeletal muscle induces an expression of heterogeneous nAChR. 16 43 Compared with denervation, the denervation-like state can be considered a state of dysfunction. In our study, we found that sepsis damaged function of motor nerve, including CMAP amplitude of and decreased MCV. Ulinastatin, a protease inhibitor, was administered to septic rats. Ulinastatin can improve resistance to vecuronium induced by sepsis and inhibit the expression of heterogeneous nAChRs. The effects of ulinastatin included two aspects: (i) ulinastatin inhibit proinflammatory cytokine release, especially TNF-a and IL-6, which serve as moderators of muscle dysfunction and cytokine-mediated muscle damage; 44 45 and (ii) the nerve-induced electrical activity suppresses the expression of a7-and g-nAChR. 46 Ulinastatin increases acetylcholine release at the neuromuscular junction and enhances neuromuscular electrical activity. 21 In summary, this study demonstrates that the pharmacodynamics of NMBA changes in sepsis is associated with the expression of a7-and g-nAChR in the skeletal muscle. Ulinastatin can improve the effects of systemic inflammation on the expression of these receptors.
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